Novel immunotherapies in multiple myeloma – chances and challenges
In this review article, we summarize the latest data on antibody-drug conjugates, bispecific T-cell-engaging antibodies, and chimeric antigen receptor T cells in the treatment of multiple myeloma. We discuss the pivotal questions to be addressed as these new immunotherapies become standard agents i...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Ferrata Storti Foundation
2021-07-01
|
| Colección: | Haematologica |
| Acceso en línea: | https://haematologica.org/article/view/10313 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|